3 results  1 of 1 

1 Daclatasvir와 Asunapreiver 요법에 실패한 만성 C형간염의 다른 직접작용 항바이러스제 재치료
Dong Hoon Lee, Soo Hyung Ryu, Hee jun Myung, Yun Jae Shin, Si Hyeong Lee, Tae Young Park, Jeong Seop Moon
Korean J Gastroenterol.2021;77(2):88-91.   Published online 2021 February 25     DOI: http://dx.doi.org/10.4166/kjg.2020.145
      
2 Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study
Seung Kak Shin, Jin-Woo Lee, Hannah Ra, Oh Sang Kwon, Jong-Beom Shin, Young-Joo Jin, Sangheun Lee, Ki Jun Han, Young Nam Kim, Tae Hun Kim, Yun Soo Kim, Ju Hyun Kim
J Korean Med Sci.2019;34(41):e264.  Published online 2019 September 30     DOI: http://dx.doi.org/10.3346/jkms.2019.34.e264
      
3 New direct-acting antivirals for the treatment of chronic hepatitis C
Sook-Hyang Jeong
J Korean Med Assoc.2015;58(12):1154-1158.   Published online 2015 December 18     DOI: http://dx.doi.org/10.5124/jkma.2015.58.12.1154
      

 1 of 1